P. Jeffrey Conn,Craig W. Lindsley,Kyle A. Emmitte,Julie L. Engers,Katrina A. Bollinger,Megan M. Breiner
申请号：
US15549944
公开号：
US10399948B2
申请日:
2016.02.10
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Described are negative allosteric modulators of metabotropic glutamate receptor 3 (mGlu3), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating depression, cognitive disorders, schizophrenia, Alzheimer's disease, or cancer in a subject.
